Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Urokinase in Diabetic Foot Syndrome
NCT00823225Phase 3Terminated
- Sponsor
- medac GmbH
- Start
- Jun 2008
- Primary completion
- Jun 2009
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of urokinase in diabetic foot disease (DFD), critical limb ischemia (CLI), sponsored by medac GmbH. Started Jun 2008; status: terminated.
02
Drugs
urokinase
03
Conditions
diabetic foot disease (DFD)critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT00823225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00823225.